Reviews

• Aciclovir for Bell's palsy (idiopathic facial paralysis) (Cochrane Review)
• Aldose reductase inhibitors for the prevention and treatment of diabetic peripheral neuropathy (This review has been withdrawn by the editorial group. Abstract not available)
• Corticosteroids for Bell's palsy (idiopathic facial paralysis) (Cochrane Review)
• Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy (Cochrane Review)
• Corticosteroids for Guillain-Barré syndrome (Cochrane Review)
• Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy (Cochrane Review)
• Immunosuppressive treatment for multifocal motor neuropathy (Cochrane Review)
• Immunotherapy for IgM anti-Myelin-Associated Glycoprotein paraprotein-associated peripheral neuropathies (Cochrane Review)
• Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy (Cochrane Review)
• Intravenous immunoglobulin for Guillain-Barré syndrome (Cochrane Review)
• Intravenous immunoglobulin for myasthenia gravis (Cochrane Review)
• Local corticosteroid injection for carpal tunnel syndrome (Cochrane Review)
• Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders (Cochrane Review)
• Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome (Cochrane Review)
• Plasma exchange for Guillain-Barré syndrome (Cochrane Review)
• Plasma exchange for myasthenia gravis (Cochrane Review)
• Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy (Cochrane Review)
• Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease (Cochrane Review)
• Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) (Cochrane Review)
• Scapular fixation in muscular dystrophy (Cochrane Review)
• Surgical treatment options for carpal tunnel syndrome (Cochrane Review)
• Surgical versus non-surgical treatment for carpal tunnel syndrome (Cochrane Review)
• Treatment for Lambert-Eaton myasthenic syndrome (Cochrane Review)

Protocols

• Acupuncture for Bell's palsy (Cochrane Protocol)
• Amino acids for amyotrophic lateral sclerosis (ALS) / motor neuron disease (MND) (Cochrane Protocol)
• Antioxidant treatment for amyotrophic lateral sclerosis / motor neuron disease (Cochrane Protocol)
• Ciliary neurotrophic factor for amyotrophic lateral sclerosis/motor neuron disease (Cochrane Protocol)
• Corticosteroids for myasthenia gravis (Cochrane Protocol)
• Drug therapy for chronic idiopathic axonal polyneuropathy (Cochrane Protocol)
• Drug treatment for facioscapulohumeral muscular dystrophy (Cochrane Protocol)
• Electrical stimulation for Bell's palsy (Cochrane Protocol)
• Enteral feeding for amyotrophic lateral sclerosis/motor neuron disease (Cochrane Protocol)
• Exercise for peripheral neuropathy (Cochrane Protocol)
• Glucocorticoid corticosteroids for Duchenne muscular dystrophy (Cochrane Protocol)
• Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis (Cochrane Protocol)
• Immunosuppressive agents for myasthenia gravis (Cochrane Protocol)
• Immunotherapy for inclusion body myositis (Cochrane Protocol)
• Interventions for the treatment of Morton's neuroma (Cochrane Protocol)
• Non-antiepileptic drugs for trigeminal neuralgia (Cochrane Protocol)
• Pharmacological and nutritional treatment for McArdle's disease (Glycogen storage disease type V) (Cochrane Protocol)
• Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy (Cochrane Protocol)
• Rehabilitation interventions for foot drop in neuromuscular disease (Cochrane Protocol)
• Rehabilitation treatments following carpal tunnel surgery (Cochrane Protocol)
• Strength training and aerobic exercise training for muscle disease (Cochrane Protocol)
• Tramadol for neuropathic pain (Cochrane Protocol)
• Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease (Cochrane Protocol)
• Treatment for dysphagia in chronic muscle disease (Cochrane Protocol)
• Treatment for human immunodeficiency virus-related distal symmetrical polyneuropathy (Cochrane Protocol)
• Treatment for meralgia paraesthetica (Cochrane Protocol)
• Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease (Cochrane Protocol)